Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROTEM evaluation of oxytocin doses in cesarean delivery
NCT02063568Withdrawn
- Sponsor
- Duke University
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Duke University. Primary endpoint: coagulation as assessed by ROTEM. Planned start Jan 2015; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02063568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02063568.